Abstract
Leishmaniasis is a neglected tropical disease caused by the protozoan of the genus Leishmania and is considered endemic in Brazil. Currently available treatments are highly toxic (not very selective) and expensive, which has led the scientific community to investigate potential new drugs that specifically target the disease.In this context, two enzymes constitute attractive targets, espec…